Clinical Research Division, Fred Hutch
Dr. Ryan Cassaday’s research interests and clinical practice are almost exclusively devoted to adults with acute lymphoblastic leukemia, or ALL. He is the principal investigator on investigator-initiated and industry-sponsored clinical trials in adult ALL. He is particularly interested in developing novel chemotherapy strategies for high-risk populations, including older adults and those with relapsed/refractory disease, as well as in using measurable residual disease as a risk-stratification tool — to help distinguish between higher- and lower-risk forms of ALL — in both standard and investigational therapies.
Division of Hematology, University of Washington School of Medicine
University of Washington/Fred Hutch, 2013, Hematology/Oncology Fellowship
University of Wisconsin Hospital & Clinics, 2010, Internal Medicine Residency
University of Wisconsin School of Medicine & Public Health, 2007, M.D.
Study Number: 9458
Study Number: 9770
Study Number: 20180357
Study Number: 9916
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.